Mark Cuban Cost Plus Drug Company partners with OncoPower to provide cost savings to cancer patients

The collaboration focuses on pricing transparency, affordable access and engaging cancer patients at home to ensure treatment adherence.
Sandra Levy
Senior Editor
Sandra Levy profile picture

The Mark Cuban Cost Plus Drug Company, PBC and OncoPower (owned by Witty Health) are joining forces to build on OncoPower’s cancer care support with the launch of a Medication Savings Suite.

The collaboration leverages Cost Plus Drugs competitive pricing on generic medication to allow the cancer patients that use OncoPower to look up pricing and order less expensive medications.

This Medication Savings Suite integrates with OncoPower’s Pill Reminder tool, creating an end-to-end experience for the patient that improves treatment adherence, provides cost transparency, engages the patient at home and is completely free, opening up affordable access to supportive care for every cancer patient.

[Read more: Mark Cuban invests in Truepill]

OncoPower was launched by Witty Health as a response to the increasing complexity found in cancer care and the challenges that patients face in understanding and identifying the right clinical trials for participation. OncoPower is both an app and website with a social media-style format in which patients and providers support one another, patients have access to professionals and engaging tools for treatment adherence and clinical trial mapping. Both OncoPower and Cost-Plus Drugs have focused on direct to consumer messaging and this collaboration grows out of mutual values of transparent information and supporting patients through their care journey, the company said.

“We are excited to work with OncoPower to bring lower prescription drug prices to consumers,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “Cost Plus Drugs and OncoPower share a common goal of providing consumers the lowest possible price for their prescription medication. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes.”

The relationship with OncoPower creates an additional channel for Cost Plus Drugs to offer its low-cost generic medications directly to a community of cancer patients, a patient population that struggles with taking many different medicines. OncoPower also is launching an enhanced version of their Pill Reminder tool. OncoPower will alert patients of cheaper medication alternatives when they use Pill Reminder, fusing treatment adherence and cost transparency at point of care for the patient. OncoPower patients also will be taken directly to Cost Plus Drugs online pharmacy to have drugs delivered to their homes.

[Read more: Mark Cuban Cost Plus Drug Company partners with EmsanaRx]

“Cancer patients are often left to navigate a very complex and disparate healthcare world largely on their own,” said Whitney Isola, co-founder and COO of Witty Health. “Bringing care tools and high-quality clinical trial information to patients in one supportive care space is at the heart of what we do. Working with companies like Cost Plus Drugs gives us the ability to deliver a world-class product with information on treatment options and medications at prices that patients can afford.”